Membrane protein degradation specialist Laigo Bio has completed the final close of its €17m (US$18.5m) seed financing. Funds will go towards the oncology and auto-immunity programmes based on the company’s bispecific antibody platform for hard-to-treat targets.
Swiss biotech company Anaveon has appointed a new Chief Executive Officer. As the company announced in March, experienced biopharma executive Thaminda Ramanayake will take over the leadership of the Basel-based firm.
Novartis is pressing ahead with its aggressive expansion strategy in oncology, striking again: the Basel-based group is acquiring a novel PI3Kalpha inhibitor from Synnovation Therapeutics for up to USD 3 billion.
https://european-biotechnology.com/wp-content/uploads/2025/10/NOVARTIS-HQ_508908319_Michael-Derrer-Fuchs--e1761645824248.jpg538958Georg Kääb/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngGeorg Kääb2026-03-20 13:55:512026-03-20 13:55:51Novartis strikes another billion-dollar oncology deal with acquisition of an early PI3Kalpha oral therapy
The Unified Patent Court and the unitary patent were established to make patent litigation in Europe easier, faster and more affordable. It has been particularly emphasized that the new system was designed to enable small and medium-sized enterprises to enforce their rights more effectively and rapidly. The reality now suggests differently. Litigation in Europe has become quite fragmented, more complex and more expensive than ever – a nice playground for deep pockets.
https://european-biotechnology.com/wp-content/uploads/2024/05/EBM_IP_Ute_Kilger.jpg489869Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2026-03-19 12:08:132026-03-19 12:08:13Is the Unified Patent Court affordable for small biotechs?
The AI Circular Economy Conference 2026, organised by nova-Institute, brought together 116 participants from 15 countries in Cologne and online to explore the transformation of the chemical and materials industry supported and accelerated by artificial intelligence.
Featuring 100 exhibitors, keynote and podium speakers, behind-the-scenes access to a leading biotech campus, and a rich networking program, SLAS Europe 2026 is designed for professionals at every stage of their careers.
https://european-biotechnology.com/wp-content/uploads/2026/03/SLAS-EU26-Banner_16x9.jpg450800Uta Mommert/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngUta Mommert2026-03-18 12:03:472026-03-18 12:14:52A special look at SLAS Europe Conference
Biotech is entering its automated era. Robots run assays, AI designs molecules, and data drives decisions. For young scientists, the question is not survival, it is leadership. Will you adapt to the new lab, or help define it?
Austria’s biotech sector is gaining momentum as the EU Biotech Act opens new opportunities. BIOTECH AUSTRIA and EuropaBio join forces to strengthen innovation, competitiveness, and Europe’s role as a global biotech leader.
Discover ELRIG’s quarter two events – three focused scientific meetings showcasing the newest technologies, models, and strategies redefining drug discovery. Join global experts advancing complex cellular systems, automation, and innovative target screening.
https://european-biotechnology.com/wp-content/uploads/2026/03/elrig.jpeg450800Uta Mommert/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngUta Mommert2026-03-18 11:07:022026-03-18 11:24:38Leading Science this Spring & Summer
The Basel-based pharmaceutical group Roche is pressing ahead with its digital strategy and setting new benchmarks for the industry. Together with NVIDIA, the company is building an “AI factory” that will become the largest computing infrastructure ever announced by a pharma company. In the race among pharma majors, Roche has now overtaken the supercomputer recently unveiled by Eli Lilly.
https://european-biotechnology.com/wp-content/uploads/2025/09/Genetech_320984427_b8PYYp7YaXx5WBi6WwRXFIg8OupDixUA-e1756802020857.jpg5631000Georg Kääb/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngGeorg Kääb2026-03-18 09:29:232026-03-18 09:29:23Swiss Roche builds its own AI factory with NVIDIA – with Genentech in California
Dutch biotech Laigo Bio bags €17m in oversubscribed seed round
Latest NewsMembrane protein degradation specialist Laigo Bio has completed the final close of its €17m (US$18.5m) seed financing. Funds will go towards the oncology and auto-immunity programmes based on the company’s bispecific antibody platform for hard-to-treat targets.
Leadership change
AppointmentsSwiss biotech company Anaveon has appointed a new Chief Executive Officer. As the company announced in March, experienced biopharma executive Thaminda Ramanayake will take over the leadership of the Basel-based firm.
Novartis strikes another billion-dollar oncology deal with acquisition of an early PI3Kalpha oral therapy
Latest NewsNovartis is pressing ahead with its aggressive expansion strategy in oncology, striking again: the Basel-based group is acquiring a novel PI3Kalpha inhibitor from Synnovation Therapeutics for up to USD 3 billion.
Is the Unified Patent Court affordable for small biotechs?
BackgroundThe Unified Patent Court and the unitary patent were established to make patent litigation in Europe easier, faster and more affordable. It has been particularly emphasized that the new system was designed to enable small and medium-sized enterprises to enforce their rights more effectively and rapidly. The reality now suggests differently. Litigation in Europe has become quite fragmented, more complex and more expensive than ever – a nice playground for deep pockets.
Recap AI Circular Economy Conference 2026
Sponsored PublicationsThe AI Circular Economy Conference 2026, organised by nova-Institute, brought together 116 participants from 15 countries in Cologne and online to explore the transformation of the chemical and materials industry supported and accelerated by artificial intelligence.
A special look at SLAS Europe Conference
AssociationsFeaturing 100 exhibitors, keynote and podium speakers, behind-the-scenes access to a leading biotech campus, and a rich networking program, SLAS Europe 2026 is designed for professionals at every stage of their careers.
Stop pipetting and start coding?
AssociationsBiotech is entering its automated era. Robots run assays, AI designs molecules, and data drives decisions. For young scientists, the question is not survival, it is leadership. Will you adapt to the new lab, or help define it?
European Partnerships for Biotech
AssociationsAustria’s biotech sector is gaining momentum as the EU Biotech Act opens new opportunities. BIOTECH AUSTRIA and EuropaBio join forces to strengthen innovation, competitiveness, and Europe’s role as a global biotech leader.
Leading Science this Spring & Summer
AssociationsDiscover ELRIG’s quarter two events – three focused scientific meetings showcasing the newest technologies, models, and strategies redefining drug discovery. Join global experts advancing complex cellular systems, automation, and innovative target screening.
Swiss Roche builds its own AI factory with NVIDIA – with Genentech in California
Latest NewsThe Basel-based pharmaceutical group Roche is pressing ahead with its digital strategy and setting new benchmarks for the industry. Together with NVIDIA, the company is building an “AI factory” that will become the largest computing infrastructure ever announced by a pharma company. In the race among pharma majors, Roche has now overtaken the supercomputer recently unveiled by Eli Lilly.